System for implanting a microstimulator

• US 6,214,032 B1
• Filed: 01/25/2000
• Issued: 04/10/2001
• Est. Priority Date: 02/20/1996
• Status: Expired due to Term

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Advanced Bionics Corporation (Sonova Holding AG)
• Inventors: Loeb, Gerald E., Richmond, Frances J. R.
• Primary Examiner(s): EVANISKO, GEORGE ROBERT
• Application Number:
  US09/490,922
• Time in Patent Office: 441 Days
• Field of Search: 607/1-3, 607/48-52, 607/59-61, 607/46, 128/877, 600/554, 600/302, 600/377
• US Class Current: 607/1
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/36003 of motor muscles, e.g. for walking assistance
• CPC Class Codes: A61N 1/3605 Implantable neurostimulators for stimulating central or peripheral nerve system
• CPC Class Codes: A61N 1/37205 Microstimulators, e.g. implantable through a cannula
• CPC Class Codes: A61N 1/37211 Means for communicating with stimulators
• CPC Class Codes: A61N 1/37235 Aspects of the external programmer
• CPC Class Codes: A61N 1/375 Constructional arrangements, e.g. casings
• CPC Class Codes: A61N 1/3756 Casings with electrodes thereon, e.g. leadless stimulators

Abstract

Improved implantable microstimulators are covered with a biocompatible polymeric coating in order to provide increased strength to the capsule and to capture fragments of the microstimulator should it become mechanically disrupted. Such coating also makes the microstimulator safer and easier to handle. The coating may include one or more diffusible chemical agents that are released in a controlled manner into the surrounding tissue. The chemical agents, such as trophic factors, antibiotics, hormones, neurotransmitters and other pharmaceutical substances, are selected to produce desired physiological effects, to aid, support or to supplement the effects of the electrical stimulation. Further, microstimulators in accordance with the invention provide systems that prevent and/or treat various disorders associated with prolonged inactivity, confinement or immobilization of one or more muscles. Such disorders include pressure ulcers, venous emboli, autonomic dysreflexia, sensorimotor spasticity and muscle atrophy. The microstimulator systems include external control for controlling the operation of the microstimulators. The control includes memory for programming preferred stimulation patterns for later activation by the patient or caregiver.

Claims

1. A microstimulator and insertion system comprising:

(a) a microstimulator;

(b) a cannula comprising a rigid, dielectric material;

(c) a trocar comprising an electrically conductive rod with a sharpened point, wherein said trocar is removably insertable into said cannula, wherein said cannula, with said trocar inserted therein, is removably insertable into the muscle tissue, thereby removably inserting the sharpened point into the muscle tissue;

(d) electrical stimulus means for applying electrical stimulus to said trocar;

wherein said trocar conducts the electrical stimulus to the muscle tissue; and

(e) a blunt-ended push-rod, which is removably insertable into said cannula, for pushing said microstimulator through said cannula and into the muscle tissue.

2. The system of claim 1 wherein the cannula has sufficient lubricity to permit the easy passage of the microstimulator without scratching exterior surfaces of the microstimulator.

3. The system of claim 1 wherein said microstimulator comprises a hermetically-sealed housing, at least two exposed electrodes for providing electrical current to stimulate surrounding tissue, and electronic circuit means within the housing for generating the electrical current.

4. The system of claim 3 wherein the electronic circuit means is adapted to be powered and controlled by external signals.

5. The system of claim 3 wherein the electronic circuit means includes a battery which allows operation of the electronic circuit means in the absence of external signals.